202 related articles for article (PubMed ID: 16474259)
1. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
[TBL] [Abstract][Full Text] [Related]
2. Candidal bloodstream infection: will prevention work?
Lum LC
Pediatr Crit Care Med; 2006 Mar; 7(2):184-5. PubMed ID: 16531952
[No Abstract] [Full Text] [Related]
3. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
4. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit.
Costello JM; Morrow DF; Graham DA; Potter-Bynoe G; Sandora TJ; Laussen PC
Pediatrics; 2008 May; 121(5):915-23. PubMed ID: 18450894
[TBL] [Abstract][Full Text] [Related]
5. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
7. Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome.
Hagen SA; Craig DM; Martin PL; Plumer DD; Gentile MA; Schulman SR; Cheifetz IM
Pediatr Crit Care Med; 2003 Apr; 4(2):206-13. PubMed ID: 12749654
[TBL] [Abstract][Full Text] [Related]
8. Extubation failure in pediatric intensive care incidence and outcomes.
Baisch SD; Wheeler WB; Kurachek SC; Cornfield DN
Pediatr Crit Care Med; 2005 May; 6(3):312-8. PubMed ID: 15857531
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.
Wenzel RP; Gennings C
Clin Infect Dis; 2005 Sep; 41 Suppl 6():S389-93. PubMed ID: 16108005
[TBL] [Abstract][Full Text] [Related]
11. Short-course amphotericin B therapy for candidemia in pediatric patients.
Donowitz LG; Hendley JO
Pediatrics; 1995 Jun; 95(6):888-91. PubMed ID: 7761216
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Avila-Aguero ML; Canas-Coto A; Ulloa-Gutierrez R; Caro MA; Alfaro B; Paris MM
Int J Infect Dis; 2005 Mar; 9(2):90-5. PubMed ID: 15708324
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study.
Linder N; Levit O; Klinger G; Kogan I; Levy I; Shalit I; Ashkenazi S; Sirota L
J Hosp Infect; 2004 Aug; 57(4):321-4. PubMed ID: 15262393
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Mondal RK; Singhi SC; Chakrabarti A; M J
Pediatr Crit Care Med; 2004 Nov; 5(6):561-5. PubMed ID: 15530193
[TBL] [Abstract][Full Text] [Related]
16. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.
Rangel-Frausto MS; Wiblin T; Blumberg HM; Saiman L; Patterson J; Rinaldi M; Pfaller M; Edwards JE; Jarvis W; Dawson J; Wenzel RP
Clin Infect Dis; 1999 Aug; 29(2):253-8. PubMed ID: 10476721
[TBL] [Abstract][Full Text] [Related]
17. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
18. Drug use density in critically ill children and newborns: analysis of various methodologies.
Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
20. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
